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Ischemic Post Conditioning Protects Both Adult and Aged Sprague Dawley
Rat Hearts from Ischemia/Reperfusion Injury Through the PI3K/Akt and
eNOS Pathway
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BACKGROUND Ischemic heart disease is considered to be one of the
most common and severe disease in elder people. In recent years the
trend of its incidence increased year by year. The world health orga-
nization (who) predicts that by 2020, ischemic heart disease will
replace infectious diseases as the world’s most deadly diseases.
Nowadays, it is still the key factor whether you open the occlusion of
coronary arteries in time that you can effectively restore the blood
perfusion of ischemic myocardium, is to limit and reduce myocardial
infarction size, which is also the key to improve prognosis. With
development of thrombolysis therapy and percutaneous coronary
intervention (PCI) the ischemic heart disease such as coronary heart
disease, acute myocardial infarction has a better prognosis now. But
occlusion of coronary artery recanalization, ischemic myocardial tis-
sue after reperfusion which caused myocardial ischemia-reperfusion
injury (Ischemia reperfusion injury, IRI) kind of inﬂuence the treat-
ment effect. Therefore, how to reduce the reperfusion injury, pro-
tection of ischemic myocardium has become the important research
content. The concept of ischemic pre-conditioning, ischemic post-
conditioning offered a possible way to protect and alleviate myo-
cardial ischemia-reperfusion injury. Since 2003 after ischemic
preconditioning concept to today, from laboratory to clinical, a large
number of animal experiments and clinical studies conﬁrmed that the
adaptation after ischemia as a kind of effective and feasible means to
provide many beneﬁts for patients with acute myocardial ischemia.
However, questions about adaptation after ischemia has not
completely solved, adaptive to reperfusion injury after ischemia
protection research mostly built on health animal models, and in
sugar or fat, the role of the elderly and other pathologic conditions
remains to be studied. Aging condition of ischemia effect how to
adapt to the heart of the protection is still controversial.
METHODS
Object
To study the protective effect of ischemia post-conditioning on rat’s
acute myocardial ischemia/reperfusion(I／R)injury and the mecha-
nism of Akt and eNOS through the cardiac protection.
Methods
Using the Langendorff reperfusion system to establish an ex vivo rat
model of whole heart ischemia/reperfusion. Use Multi-conductive
physiological recorder to record cardiac fuction as CF、HR、LVDP、
dp/dt max of all groups were recorded. Six rat hearts of each group
were used to determine myocardial infarct size by dual staining with
triphenyltetrazolium chloride and Evan’s blue dye. The other rabbits
of each group were saved for western blotting analysis as the
expression of Akt、P-Akt、eNOS and P-eNOS.
RESULTS 1) The cardiac function (LVDP anddp/dtmax) of adult/aged
IPoc group was signiﬁcantly better than that of the IRI group (P<0.05).
2) The infarction area of adult/aged IPoc group was smaller than that
of the IRI group (P<0.05). 3) The expression of P-Akt and P-eNOS of all
adult/aged IPoc groups was signiﬁcantly higher than that of the IRI
groups (P<0.05).
CONCLUSION 1) Given the post condition dispose at the very begin-
ning of the reperfusion can active PI3K-Akt and eNOS kinase to
establish the cardiac protect function, which can reduce infarct size
and improve cardiac function on both adult and aged Wistar rat heart.
2) The post condition procedure active Akt and enos through phos-
phorylation.
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BACKGROUND We experienced two cases of longitudinal stent elon-
gation (LSE) during stent deployment and disclose that LSE occurs
when stents were expanded in air pressure and in malapposition
vessel models.
METHODS Following tests were performed to disclose the occurrence
LSE.
Test1: Five kinds of drug eluting stents (DES: Xience Xpedition
(XPD), Plomus Premier (PP), Nobori (N), Resolute Integrity (RI) andCypher select plus (CY)) with three 3x28 or 3x26mm stents of each
were used. All stents were implanted in a phantom model with the
diameter being 3mm at nominal pressure achieving good apposition
and single post-dilation to mid portion of the stents was performed
using 3.5x15mm high-pressure balloon catheter (HP) at rated burst
pressure (RBP).
Test2: All stents except CY were dilated three times at RBP in air
pressure (non-stenotic model). Secondary, the tube 2mm in diameter
and 5mm in length were put on the stents and stents were dilated
three times at RBP in air pressure (stenotic model).
Test3: Three 3 x 28mm Multilink Vision stents put on the tube 2mm
in diameter and 5mm length (Short) or 15mm length (Long) of each
were dilated three times at RBP in air pressure.
RESULTS Four new DESssigniﬁcantly elongated than CY in a apposi-
tion phantom model and less elongatedat the stenotic model
than non-stenotic model. Moreover, stent elongationdepends on the
stenotic length, namely, stents elongated less at the longstenotic
lesions.Test 1 (mm) XPD PP N RI CY102.9  0.21 102.54  0.71 102.07  0.26 103.42  0.44 100.3  0.51 P < 0.05Test 2 (mm) NON-STENOTIC STENOTIC109.89  2.41 108.79  1.88 P < 0.05Test 3 (mm) Short Long108.26  0.03 105.01  0.22 P < 0.05CONCLUSION LSE was observed all kinds of DESs especially in new
generation ones in apposition model. However, it seems to less
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Left Main PCI in a Peripheral Centre Without IABP: Immediate and Long
Term Results
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BACKGROUND Interventional cardiologist occasionally comes across
patients with critical lt. main lesions who are either hemodynamically
compromised or have severe angina, ECG changes warranting urgent
PCI especially if urgent CABG cannot be done. This is particularly
challenging in peripheral center with limited resources and facilities.
This study is aimed to study feasibility, efﬁcacy, and long term results
of left main PCI in peripheral center. First left main PCI was done as
PAMI in cardiac arrest survivor in cardiogenic shock. He had total left
main off. He miraculously survived. Subsequent left main PCI pro-
cedures though predominantly were salvage later were done on elec-
tive basis.
METHODS A total of 27 patients underwent Left Main PTCA at
Ashwini Sahakari Rugnalaya, Solapur, a semi-urban area of Mahara-
shtra. 1stLeft Main PTCA was done on 16/02/2008 and last on 01/04/
2014. Initially left main PTCA was done only as a rescue lifesaving or
as primary intervention in STEMI. Subsequently it was also done as
elective procedure when anatomy was suitable. Out of 27, 19 were
males and 8 females, age ranged from 35 years to 91 years with mean
age of 60.4. Left main as rescue procedure was done in 17 patients
when immediately after CAG patient had either severe chest pain,
hemodynamic compromise and in 1 patient dissection of left main. In
7 patients left main was done as PAMI for STEMI and in 2 patients it
was an elective procedure. IABP was not used in any patient.
RESULTS Lesion location: ostial – 16, shaft – 04, terminal – 07.
No of stents: Left main alone – 04, Left main with crossover to LAD
single stent – 14,Left main with LAD separate stents– 02,Left main with
CX – 02,Left main with RCA – 01,Left main with LAD & CX– 01,Left main
with LAD& RCA – 03.1 patient had TIMI II ﬂow ,others had good on table
result. Clinical or telephonic follow-up was available in all patients and
ranged from 4 months to 6 years. 2 patients had follow-up angiogram
.Of the 2 PCI related deaths, 1 had TIMI II ﬂow after PCI and other was in
shock at the time of PCI. Both died in hospital. Of the 3 PCI unrelated
deaths 1 patient was having chronic renal failure, stopped dialysis and
died.1 patient died of refractory heart failure 1 year later.1 patient
stopped medication after 1 month and had sudden death. 1 patient 3
years later had angina, ECG changes and developed signiﬁcant re-ste-
nosis of stent for which he successfully underwent CABG surgery.
